Electronic Nicotine Delivery System Study
This study will assess product use behaviors, biomarkers of exposure, subjective effects and safety of an electronic nicotine delivery system (ENDS) as compared to smoking your usual brand of cigarettes over 8-weeks.
The purpose of this study is to look at a drug called cytisinicline to see how effective it is at enabling people to quit smoking as compared to a placebo.
Treatment-Resistant Hypertension Study
The purpose of this study is to assess the safety and effectiveness of 3 doses of the investigational drug as compared to a placebo.
Investigational Chikungunya Vaccine
The purpose of this study is to evaluate the safety and immunogenicity of an investigational live-attenuated Chikungunya vaccine verses a placebo.
Investigational COVID-19 Vaccine
Participants must be a healthy adult 60 years of age and over with a low risk of being exposed to SARS-CoV-2.The purpose of this study is to assess the safety, tolerability, and immunogenicity of the investigational vaccine to prevent COVID-19 disease as compared to a placebo.
Dietary Supplement for Skin Infections Study
The purpose of this study is to assess the supportive role of an investigational dietary supplement when taken by subjects who are also taking previously failed antibiotics to treat an uncomplicated, community-acquired skin infections, including infections due to Methicillin-Resistant staphylococcus aureus (MRSA).
Celiac Disease Study
The purpose of this study is to evaluate the safety and effectiveness of an investigational, oral drug for celiac disease to see if it can reduce the symptoms of celiac disease (such as abdominal pain, bloating, cramping, and gas) as compared to a placebo.
Healthy Volunteers Vaccine Studies
If you are interested in participating in a vaccine study, click here and please fill out the form. This will help us determine if you meet some of the initial criteria necessary to participate.